Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants with chronic kidney disease (CKD) stage 3 (creatinine clearance \[CrCl\]/ glomerular filtration rate \[GFR\] 30 to 59 milliliter per minutes per 1.73 meter square \[mL/min/1.73m\^2\]) or Stage 4 (CrCl/GFR 15-29 mL/min/1.73m\^2) who did not require dialysis. CrCl/GFR was estimated with the Cockcroft-Gault equation or the abbreviated Modification of Diet in Renal Disease (MDRD) equation
Anemia defined as baseline Hb concentration less than (\<) 10.5 gram per deciliter (g/dL)
You may not be if
Previous therapy with any ESA within 12 weeks prior to screening
Renal allograft in place
Immunosuppressive therapy in the 12 weeks prior to screening
Overt gastrointestinal bleeding and red blood cells (RBC) transfusions within 8 weeks before screening
Clareo Health | A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
